Johnson & Johnson Covid-19 Vaccine Trial Set to Resume



Johnson & Johnson’s  (JNJ) – Get Report coronavirus vaccine trial, which was halted earlier this month due to an unexplained illness of a patient, will reportedly resume in the near future.

Shares of the New Brunswick, N.J., health-care giant closed little changed at $145.24.

An independent committee investigated the case of a man in the trial who suffered a stroke and concluded it was not related to the vaccine, the Washington Post reported. The paper cited two people familiar with the trial who spoke on condition of anonymity.





Source link

error: Content is protected !!

New Report

Close